Faculty Digital Archive

Archive@NYU >
Stern School of Business >
CeDER Published Papers >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2451/27742

Title: Personalized Pricing and Quality Differentiation
Authors: Choudhary, Vidyanand
Ghose, Anindya
Mukhopadhyay, Tridas
Rajan, Uday
Keywords: personalized pricing
quality differentiation
Issue Date: 6-Nov-2008
Series/Report no.: CeDER-PP-2006-04
Abstract: We develop an analytical framework to investigate the competitive implications of personalized pricing (PP), whereby firms charge different prices to different consumers based on their willingness to pay. We embed PP in a model of vertical product differentiation and show how it affects firms’ choices over quality. We show that firms’ optimal pricing strategies with PP may be nonmonotonic in consumer valuations. When the PP firm has high quality, both firms raise their qualities relative to the uniform pricing case. Conversely, when the PP firm has low quality, both firms lower their qualities. Although many firms are trying to implement such pricing policies, we find that a higher-quality firm can actually be worse off with PP. While it is optimal for the firm adopting PP to increase product differentiation, the non-PP firm seeks to reduce differentiation by moving in closer in the quality space. While PP results in a wider market coverage, it also leads to aggravated price competition between firms. Because this entails a change in equilibrium qualities, the nature of the cost function determines whether firms gain or lose by implementing such PP policies. Despite the threat of first-degree price discrimination, we find that PP with competing firms can lead to an overall increase in consumer welfare.
URI: http://hdl.handle.net/2451/27742
Appears in Collections:CeDER Published Papers

Files in This Item:

File Description SizeFormat
CPP-04-06.pdf198.75 kBAdobe PDFView/Open

Items in Faculty Digital Archive are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The contents of the FDA may be subject to copyright, be offered under a Creative Commons license, or be in the public domain.
Please check items for rights statements. For information about NYU’s copyright policy, see http://www.nyu.edu/footer/copyright-and-fair-use.html 
Valid XHTML 1.0 | CSS